Keerthi Reddy Ramireddy
Hospitalist · Brooklyn, NYNPI 1922569235
Payments from drug & device makers
Across 85 payments — averaging $37.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$610
- AstraZeneca$343
- Medtronic$289
- Alnylam Pharmaceuticals Inc.$287
- E.r. Squibb & Sons, L.L.C.$216
- Boehringer Ingelheim$215
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,15098%
- Education$702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $610 |
| AstraZeneca | 12 | $343 |
| Medtronic | 2 | $289 |
| Alnylam Pharmaceuticals Inc. | 11 | $287 |
| E.r. Squibb & Sons, L.L.C. | 11 | $216 |
| Boehringer Ingelheim | 8 | $215 |
| Shockwave Medical, Inc | 1 | $201 |
| Angiodynamics, Inc. | 1 | $118 |
| Amgen | 7 | $117 |
| Abbott | 1 | $115 |
| Merck | 4 | $105 |
| Cardiva Medical, Inc. | 3 | $100 |
| Actelion Pharmaceuticals US, Inc. | 3 | $91 |
| Novo Nordisk | 2 | $61 |
| Bayer | 2 | $60 |
| Terumo Medical Corporation | 2 | $56 |
| Bridgebio Pharma, Inc. | 2 | $53 |
| Kestra Medical Technology Services, Inc. | 2 | $52 |
| Pfizer | 2 | $48 |
| Heartflow, Inc. | 1 | $32 |
| Cordis US CORP. | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,220 in reported general payments places this provider in the 95th percentile of 1,860 hospitalist providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 17 | $21,803 |
| JardianceEmpagliflozin | 18 | $17,884 |
| OzempicSemaglutide | 14 | $12,568 |
| Metoprolol Succinate | 14 | $293 |
| Rosuvastatin Calcium | 32 | $266 |
| Atorvastatin Calcium | 18 | $147 |
| Spironolactone | 17 | $140 |
| Losartan Potassium | 15 | $90 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $215 | $17,88418 claims |
| Novo NordiskOzempic | $61 | $12,56814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,860 hospitalist providers in New York.
Other hospitalist in Brooklyn
- Boris AvezbakiyevBrooklyn$11K
- Bonnie BrownBrooklyn$7K
- Omid HeraviBrooklyn$6K
- Tatyana ZagoruychenkoBrooklyn$5K
- Shoa ZaidiBrooklyn$5K
- Kayur ShahBrooklyn$4K
- Mark GoldinNew Hyde Park$666K
- Nelson Chan-HungRochester$445K
- Zainab Mogul-AshrafMiddletown$393K
- Manika SuryadevaraSyracuse$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.